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Results: From 337 patients finally undergoing the planned procedure, 307 patients from 7
out of 8 sites could be followed-up (91%). Baseline parameters were identical in both
groups, 2.2±0.6 vessels were treated in CABG patients, while 1.9±0.5 vessels were
treated in PTCA patients. 37% of surgical patients received internal mammary artery
grafts, while no stents were used in patients undergoing PTCA. At the end of the
13.6±1.5 year follow-up period, degree of angina, degree of dyspnoe and utilization of
nitrates were identical in both groups. With a total number of 76 deaths, Kaplan-Meyer
analysis revealed a comparable mortality distribution in both groups. The time to first
reintervention was significantly shorter in patients undergoing PTCA, p<0.001. While the
number of reinterventions (CABG = 97, PTCA = 139, ns) and crossover rates (CABG to
PTCA = 50, PTCA to CABG = 53, ns) were comparable in both groups, distribution was
distinctly different with more early interventions in patients assigned to PTCA.
Conclusion: The results of our 13.6-year follow-up suggest that in patients with symptom-
atic multivessel disease, both PTCA and CABG are associated with a comparable long-
term survival and symptomatic efficacy. In how far these results may be altered by devel-
opments such as drug eluting stents or new surgical techniques remains to be deter-
mined.
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Background: Prior studies reporting improved outcomes for obese patients (pts) follow-
ing percutaneous coronary intervention (PCI) had variable stent and glycoprotein IIbIIIa
inhibitor (GPI) use and did not report target vessel revascularization (TVR).
Methods: The TARGET trial compared short and long-term outcomes of pts randomized
to receive tirofiban or abciximab for intent-to-stent PCI.
Results: 36% of 4,789 pts were obese (body-mass index [BMI] >30). Obese pts were
younger (59±11 vs. 63.7±11 years, p<0.001), with more females (30 vs. 24%, p<0.001)
and diabetics (33 vs. 18%, p<0.001). Major bleeding was lower in the obese (0.4 vs.
1.1%, p<0.02). Obese and non-obese pts had a similar incidence of 30-day death, myo-
cardial infarction and urgent TVR (6.8 vs. 7.5%, p=ns). Death and myocardial infarction at
6 months were also similar (8.2 vs. 7.9%, p=ns). There was a “U” shaped relationship
between BMI and TVR with higher TVR in pts in the highest quartile (>32) of BMI (11 vs.
9%, p<0.01) particularly in pts <age 65 (12 vs. 8%, p=0.003). TVR in low BMI pts was not
significantly different in this small cohort compared to other pts. Excluding diabetics, the
“U” shaped relationship persisted with a trend to higher TVR in pts < age 65 with BMI >32
(11 vs. 8.0%, p=0.098).
Conclusion: Obese pts have significantly higher TVR after coronary stenting. Obese pts,
although younger, do not have fewer short or long-term ischemic events following PCI
with routine use of GPI and stents. The obese have a lower incidence of major bleeding.
1138-44 Platelet Glycoprotein IIIa Genotype Is Not a Risk Factor 
for Target Vessel Revascularization Following 
Percutaneous Coronary Intervention
Laxmi S. Mehta, Kimberly A. Skelding, Demetri Demetrious, Mark Emerick, Judith Boura, 
James A. Goldstein, William W. O'Neill, William Beaumont Hospital, Royal Oak, MI
Background: The platelet glycoprotein IIIa polymorphism has been shown to be associ-
ated with an increased risk for restenosis post–percutaneous coronary intervention (PCI)
in one prior study. The IIIa component of this complex has a known genetic polymor-
phism (PLA) with 2 known alleles A1 and A2. We sought to delineate whether PLA2 is an
independent risk factor for target vessel revascularization (TVR) following PCI.
Methods: We prospectively analyzed the PLA genotype through peripheral blood sam-
pling in 553 patients undergoing PCI at William Beaumont Hospital, Royal Oak, Michi-
gan. Clinical variables were collected at baseline and follow-up was performed by
telephone contact. Patients or family members were queried with regard to TVR, myocar-
dial infarction (MI) and death at 2 years.
Results: The A2/A2 genotype was present in only 14 patients (2%), A1/A2 was present in
131 patients (24%) and A1/A1 in 408 patients (74%). There was no difference within the
groups A2/A2, A1/A2, and A1/A1 in terms of age (64+9 vs 66+11 vs 64+11, p=0.52) or
female gender (21% vs 25% vs 27%, p=0.84). No difference was seen in clinical history
of smoking, hyperlipidemia, hypertension, diabetes or stroke. The LAD was more com-
monly the target vessel in the A2/A2 group (50% vs 25% vs 38%, p=0.016). No difference
was seen between the groups in terms of treatment with angioplasty (14% vs 25% vs
25%, p=0.66) or stent (86% vs 70% vs 70%, p=0.46). TVR was identified in 15%, 22%,
and 20% of the patients respectively (p=0.86). The combined endpoint of TVR, MI or
death was identified in 21%, 31%, and 24% of the patients respectively at 2 years
(p=0.33).
Conclusions: PLA polymorphisms are not predictive of TVR or the combined endpoint
of TVR, MI or death.
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Background: Returning to work after revascularization is a meaningful clinical outcome
to both patients and society. Yet factors influencing patients' return to work after percuta-
neous coronary intervention (PCI) have not been thoroughly investigated. We evaluated
baseline and 1-year patient characteristics associated with returning to work after PCI.
Methods: We prospectively followed 1,360 patients undergoing PCI from February 1998
to August 2000. Data was obtained at baseline and at one year. 489 patients were work-
ing at baseline and were the focus of this analysis. The effect of demographics (age, sex,
marital status), medical comorbidities (peripheral vascular disease, cerebrovascular dis-
ease, congestive heart failure, renal dysfunction), disease severity (angina frequency,
number of diseased vessels), and health status (both baseline and at 1 year using the
Seattle Angina Questionnaire (SAQ)) were examined. SAQ is a disease specific function
tool where higher scores are reflective of better health status (better function, less
angina, and less physical limitation). Multivariable logistic regression modeling was used
to define independent predictors of returning to paid employment.
Results: At 1-year follow-up 297 (83%) of the 355 patients working at baseline ( 73% of
the original cohort on whom follow-up was available) were still working. The independent
predictors of returning to work, from the final multivariable model, were: age <60 (odds
ratio (OR) 5.1, 95% CI 2.4-10.8), being married (OR = 2.5, 95% CI 1.0-6.0), and the
absence of peripheral vascular disease (OR = 5.4, 95% CI 1.8-16.5). 22% of patients had
residual angina at 1 year. Patients without angina (SAQ Angina Frequency score =100
vs. <100) at 1-year were significantly more likely to be working compared to patients with
residual angina (OR=2.5, 95% CI 1.2-5.4, p=0.015).
Conclusions: Improvement in angina as measured by the SAQ was significantly
assocaited with returning to work following PCI. Patients who are married, younger (less
than 60), without peripheral vascular disease are also more likely to return to work.
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Background: Intracoronary PhotoPoint® photodynamic therapy (PDT) holds promise in
coronary artery disease for treating atherosclerotic vulnerable plaque and restenosis. We
have previously demonstrated that intracoronary PDT with the novel photosensitizer
drugs, MV0611 and MV0633, significantly inhibits neointima formation 14 days after bal-
loon injury in porcine coronary arteries. However, the temporal biological effects and
long-term arterial healing responses following intracoronary PDT are unknown. There-
fore, we have assessed the vascular effects and time-course for complete healing of
swine coronary arteries after intracoronary PDT.
Methods: Normolipidemic swine (n=22) were injected with photosensitizer (MV0611 or
MV0633; 3 mg/kg iv; Miravant, CA) and 4 hrs later the coronary arteries were illuminated
with light (125 J/cm2) using an endovascular catheter (3 x 30 mm; Miravant), to cause
photo-selective targeting of PDT to the vessel wall. Controls consisted of drug or light
alone. Arteries were assessed by histology at 3, 14, 30, 60 or 90 days post-PDT for
smooth muscle cell (SMC) content and re-endothelialization.
Results: All control or PDT arteries were patent at follow-up with no evidence of throm-
bosis, degeneration, or aneurysm formation. At 3 days, medial SMC’s were dramatically
reduced in PDT arterial sections, 1261 ± 397 cells/mm2 versus controls 3863 ± 109 cells/
mm2 (p < 0.001), with an absence of endothelial cells. By 14 days after PDT, SMC’s had
significantly repopulated the media (PDT: 2661 ± 124 cells/mm2 vs controls: 3701 ± 256
cells/mm2; p < 0.01) and a maximal re-endothelialization score was observed. At 30
days, medial SMC re-population was complete and at 30-90 days there were no differ-
ences in cellular populations in PDT arteries versus controls.
Conclusion: These results provide an insight into the temporal healing responses of cor-
onary arteries after intracoronary PhotoPoint PDT. Long-term normalization and stabili-
zation of the arterial wall following PhotoPoint PDT may represent a potential beneficial
aspect of this novel treatment for atherosclerotic vulnerable plaque and restenosis.
1138-63 The Impact of Ejection Fraction on Long-Term Mortality 
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Background: Congestive heart failure (CHF) has been associated with worse outcomes
for patients undergoing PTCA and CABG. The impact of low versus normal ejection frac-
tion (EF) on long-term mortality after revascularization among patients with CHF has not
been studied. Methods: The patients in the Bypass Angioplasty Revascularization Inves-
tigation (BARI) randomized trial and registry cohorts with EF measurements at baseline
